Please login to the form below
Striverdi
This page shows the latest Striverdi news and features for those working in and with pharma, biotech and healthcare.
Boehringer COPD drug 'could give patients more independence'
trials. Spiolto - which combines the active ingredients in Boehringer's long-acting muscarinic antagonist Spiriva (tiotropium) and long-acting beta agonist Striverdi (olodaterol) - was recently approved for marketing in the EU
Latest news
-
Boehringer's Spiriva combo approved in first EU markets
s recently launched Striverdi product. .
-
Boehringer bags FDA approval for Spiriva-based combo
Stiolto contains the active ingredient in Spiriva - long-acting muscarinic antagonist (LAMA) tiotropium - with long-acting beta agonist (LABA) olodaterol that is sold as a monotherapy under the Striverdi brand name.
-
FDA approves Boehringer COPD spray Striverdi Respimat
Boehringer Ingelheim's once-daily chronic obstructive pulmonary disease (COPD) spray Striverdi Respimat (olodaterol) has won a US licence. ... As a long-acting beta-adrenergic agonist (LABA) Striverdi Respimat will, in common with other drugs in that
-
Boehringer submits COPD combo in EU
The drug combines Boehringer's huge selling Spiriva (tiotropium) with another of its respiratory treatments Striverdi (olodaterol). ... Striverdi is yet to hit the same lofty heights as Spiriva, having only received approval earlier this year.
-
Novartis, Boehringer stake claims to combination COPD market
up that combines tiotropium with the company's long-acting beta agonist Striverdi (olodaterol).
More from news
Approximately 2 fully matching, plus 5 partially matching documents found.
Featured jobs
-
Account Manager / Account Director
-
Competative
-
Senior Medical Writer
-
Salary TBC
-
Business Director
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
-
Account Director
-
Competitive Salary Offered
-
Senior Account Manager
-
Competitive Salary Offered
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Global Business Development Director – Health Education
-
excellent commission
-
Account Director, Medical Education
-
Salary TBC
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Medical Writer
-
Salary TBC
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
Subscribe to our email news alerts
- Europe closer to biosimilar rule change, despite fierce resistance from pharma
- Novartis forges AI alliance with Oxford University
- FDA adcomm split on Sanofi’s type 1 diabetes drug
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Essential collaboration skills training for pharma and healthcare teams launched by Dovetail.
- Evenity back on track with FDA panel blessing in osteoporosis
PMHub
Six Degrees Medical Consulting
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...
Latest intelligence
- Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
- Healthcare leaders in the European Union should begin preparing for a breakthrough now...
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Quick links
Infographics
